
    
      Participants receive either oral Quercetin 1000 g/day or placebo for 20 weeks. Quercetin
      levels, biomarkers, ultrasounds (heart and muscle), functional assessments will be measured
      on enrollment and after the intervention. The study coordinator will contact participants
      weekly to monitor safety and ensure compliance. All quercetin administration will be
      supervised by Claudia L Campos, MD, Associate Professor of Internal Medicine, Medical
      Director Internal Medicine clinic.
    
  